Denator this week announced it has appointed Marten Winge vice president for business development.
Previously, Winge was CEO of proteomics company Proxeon, which was purchased by Thermo Fisher Scientific in April.
Waters this week announced partnerships with several researchers as part of its new Centers of Innovation Program, which the company has launched in an effort to build collaborations with scientists working on UPLC-MS platforms.
The scientists include Jeremy Nicholson, professor and chair in biological chemistry, department of surgery and cancer, Imperial College; John Engen, associate professor of chemistry and chemical biology, Northeastern University; James Scrivens, department of biological sciences, University of Warwick; and Julie Leary, department of molecular and cellular biology, University of California, Davis.